Liquidia announced that as of Aug. 1, it will only ship 340B purchases of Yutrepia to covered entities with a contract pharmacy in its limited distribution network.
Liquidia Tightens 340B Contract Pharmacy Restrictions; Biogen, Sanofi Exempt New States
A North Carolina-based drugmaker recently tightened its 340B contract pharmacy restrictions to limit distribution of a pulmonary arterial hypertension treatment—just [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
